Clinical Study on Drug Sensitivity Verification or Prediction of Therapy for Breast Cancer by Patient-Derived Organoid Model
NCT03544047
·
clinicaltrials.gov ↗
NA
Phase
UNKNOWN
Status
50
Enrollment
OTHER
Sponsor class
Conditions
Organoid
Interventions
DRUG:
Paclitaxel
Sponsor
Peking Union Medical College